Last reviewed · How we verify
NCT03517891: BAT
The Baby Act Trial (BAT): a Multimodal Lifestyle Intervention
NA trial testing WIC+ in Obesity in Childhood in 530 participants. Status unknown.
30 June 2023
Quick facts
| Lead sponsor | University of Puerto Rico |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | prevention |
| Enrollment | 530 |
| Start date | 11 May 2018 |
| Primary completion | 30 June 2023 |
| Estimated completion | 31 July 2024 |
| Sites | 1 location across Puerto Rico |
Drugs / interventions tested
- WIC+
Conditions studied
- Obesity in Childhood — all drugs for Obesity in Childhood →
Sponsor
University of Puerto Rico
Who can join
Eligibility, any sex, with Obesity in Childhood. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Childhood obesity is increasing, particularly among Hispanics. Rapid weight gain during childhood increases the risk of obesity in childhood and in adulthood, also increasing the risk of chronic diseases such as diabetes and hypertension. This can be prevented with interventions during early in life that address multiple risk factors associated with the early development of obesity. Therefore, the purpose of this study is to test an intervention to promote baby activation and improve their sleep patterns and feeding patterns from birth to 12 months of age. For this purpose, pregnant women participating in the Special Nutrition Women, Infants and Children (WIC) Program in Puerto Rico will be recruited and randomly assigned to the control group (usual care within the program) or to the WIC + group (usual care + intervention). The intervention will focus on age-appropriate physical activity for children, healthy sleep and limited time on the screen, healthy dietary patterns and growth monitoring. The content will be delivered with a multimedia approach (web platform, mobile messages and telephone follow-up). If successful, this intervention could be adopted by the WIC program in Puerto Rico to help prevent childhood obesity among its participants. This will help improve the health of minorities and eliminate health disparities among Hispanics and other at-risk groups.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Intervention to promote physical activation and improve sleep and response feeding in infants for preventing obesity early in life, the baby-act trial: Rationale and design.
Campos M, Pomeroy J, Mays MH, Lopez A, et al · · 2020 · cited 10× · PMID 33099015 · DOI 10.1016/j.cct.2020.106185 -
Baby-Act Intervention to Prevent Excessive Infant Weight Gain: Development, Implementation, Lessons Learned, and Future Applications.
Kallis Colon MG, Lopez A, Campos Rivera M, Pomeroy J, et al · · 2025 · cited 1× · PMID 40120064 · DOI 10.1007/s10995-025-04082-x
Verify or expand the search:
- PubMed search for NCT03517891
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other University of Puerto Rico trials
Trials by the same sponsor.
- NCT06425510 — Using Technology to Improve Function for Older Latinos With Disabilities in Underserved Areas · NA · not yet recruiting
- NCT07369102 — Esketamine With or Without Integration Therapy for Treatment-Resistant Depression · Phase 4 · recruiting
- NCT07039266 — Food Allergy Registry and Awareness Campaign in Puerto Rico · not yet recruiting
- NCT06917118 — Multimodal Pain Management After Wide Awake Local Anesthesia No Tourniquet Orthopedic Hand Surgery: A Randomized Control · NA · not yet recruiting
- NCT05910749 — Substance Use Disorder, Brain and Behavioral Regulation · NA · withdrawn
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03517891 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Puerto Rico
- Last refreshed: 22 November 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03517891.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing